DOSSIER · 13F Holders · Q1 2026Healthcare · In Vitro & In Vivo Diagnostic Substances
CLDX
CELLDEX THERAPEUTICS INC NEW
236 institutions still hold CELLDEX THERAPEUTICS INC NEW as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 15117B202·In Vitro & In Vivo Diagnostic Substances·236 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
236 institutions reported CLDX in Q1 2026. WELLINGTON MANAGEMENT GROUP LLP leads at 16.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 12
216 more holders available. Log in →